Company news
Filament Health Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct Psilocin Administration and First-Ever Psychedelic Botanical Drug Candidates
November 2, 2021
Filament Health to Webcast Live at VirtualInvestorConferences.com October 14th
October 13, 2021
Filament Health Announces DTC Eligibility and Up-List to the OTCQB Exchange
October 12, 2021
Filament Health Shares to Commence Trading on the OTC Market
September 7, 2021
Filament Health Files 20th Patent Application Including Three International PCT Applications
September 1, 2021
Filament Health Successfully Completes Industry-First Export of Natural GMP Psychedelics to the United States
August 26, 2021
Filament Health Announces Q2 2021 Financial Results
August 16, 2021
Filament Health is the First Public Company to be Issued a Patent for Extraction of Natural Psilocybin
August 5, 2021
Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing
July 29, 2021
Filament Health to Host Virtual Investor Event
July 19, 2021
Decks
- SPAC Merger (October 2023)
SPAC merger · 27 slides · Oct 2, 2023
- SPAC Merger (July 2023)
SPAC merger · 28 slides · Jul 24, 2023